Quick Answer
IRONWOOD PHARMACEUTICALS INC reported Total Assets of $396.90 million for the year ending 2025.
- IRONWOOD PHARMACEUTICALS INC showed an increase of +13.1% in Total Assets from 2024 to 2025.
- This data is from IRONWOOD PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $249.73 million | Q3 2011: $219.48 million | Q1 2012: $249.18 million | Q2 2012: $208.66 million | Q3 2012: $246.52 million | Q1 2013: $325.09 million | Q2 2013: $384.03 million | Q3 2013: $325.84 million | Q1 2014: $418.87 million | Q2 2014: $371.06 million | Q3 2014: $346.17 million | Q1 2015: $305.53 million | Q2 2015: $653.94 million | Q3 2015: $613.43 million | Q1 2016: $603.33 million | Q2 2016: $700.21 million | Q3 2016: $731.98 million | Q1 2017: $701.32 million | Q2 2017: $705.08 million | Q3 2017: $625.09 million | Q1 2018: $571.10 million | Q2 2018: $618.22 million | Q3 2018: $416.65 million | Q1 2019: $363.54 million | Q2 2019: $315.72 million | Q3 2019: $334.34 million | Q1 2020: $404.01 million | Q2 2020: $443.54 million | Q3 2020: $492.32 million | Q1 2021: $599.34 million | Q2 2021: $1.01 billion | Q3 2021: $1.08 billion | Q1 2022: $1.08 billion | Q2 2022: $975.69 million | Q3 2022: $1.04 billion | Q1 2023: $1.16 billion | Q2 2023: $603.22 million | Q3 2023: $524.06 million | Q1 2024: $438.82 million | Q2 2024: $395.62 million | Q3 2024: $389.52 million | Q1 2025: $327.21 million | Q2 2025: $342.95 million | Q3 2025: $396.06 million.
- Over the full 16 years of available data (2010 to 2025), IRONWOOD PHARMACEUTICALS INC's Total Assets has grown by 31.7%.
- Historical annual values: Fiscal year 2025: $396.90 million | Fiscal year 2024: $350.91 million | Fiscal year 2023: $471.07 million | Fiscal year 2022: $1.10 billion | Fiscal year 2021: $1.13 billion | Fiscal year 2020: $559.24 million | Fiscal year 2019: $402.75 million | Fiscal year 2018: $332.05 million | Fiscal year 2017: $605.67 million | Fiscal year 2016: $709.82 million | Fiscal year 2015: $619.12 million | Fiscal year 2014: $329.32 million | Fiscal year 2013: $278.96 million | Fiscal year 2012: $229.91 million | Fiscal year 2011: $208.98 million | Fiscal year 2010: $301.37 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: